Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Chan, Andrew T	Massachusetts General Hospital United States	MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297680-01S1	Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	5U01CA274514-03	Matthew Young, Ph.D.
Chapkin, Robert Stephen	Texas A&M Agrilife Research United States	Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling	5R01CA244359-05	Amit Kumar, Ph.D.
Chen, Grace Y.	University Of Michigan At Ann Arbor United States	Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention	5R21CA273646-02
Chen, Ru	Baylor College Of Medicine United States	BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION	4UH3CA292130-02	Claire Zhu, Ph.D.
Cheville, Andrea Lynne	Mayo Clinic Rochester United States	Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial	5R33CA278594-04	Brennan Streck, Ph.D., RN, M.P.H.
Chiang, Cheng-Ming	Ut Southwestern Medical Center United States	Small Compound Inhibitors Targeting HPV Genome Replication	1R01CA288743-01A1
Chibwesha, Carla J	Univ Of North Carolina Chapel Hill United States	Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV	5R01CA250850-05	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Chinnaiyan, Arul M	University Of Michigan At Ann Arbor United States	Michigan-VUMC Biomarker Characterization Center	5U2CCA271854-04	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chirenje, Zvavahera Mike	University Of California, San Francisco United States	Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)	3UG1CA284918-03S1	Maria Silvina Frech, Ph.D., M.S.
Chong, Catherine Daniela	Mayo Clinic Arizona United States	Biomarker Signature to Predict the Persistence of Post-Traumatic Headache	5R33NS113315-03	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Chung, Raymond T	Massachusetts General Hospital United States	Trial of Statins for Chemoprevention in Hepatocellular Carcinoma	4R01CA255621-05	Asad Umar, D.V.M., Ph.D.
Chung, Michael Hoonbae	Emory University United States	HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)	3UG1CA275400-04S1	Maria Silvina Frech, Ph.D., M.S.
Chung, Ki Young	Prisma Health - Upstate United States	NCORP of the Carolinas (Greenville Health System NCORP)	3UG1CA189972-11S1	Vanessa A. White, M.P.H.
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis	5R01CA262551-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND